In summary, SPP1 produced by proinflammatory lung-infiltrating macrophages might be an upstream activator of the aberrant innate response in COVID-19 by driving proinflammatory activity of CD14+ monocytes and differentiation of CD274+ (PD-L1+) neutrophils that suppress adaptive immunity and support inflammation. This evidence concerns the gene SPP1 and COVID-19.